Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.

Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, Jung JU.

Cell Host Microbe. 2013 Apr 17;13(4):452-64. doi: 10.1016/j.chom.2013.03.006. Erratum in: Cell Host Microbe. 2013 Nov 13;14(5):600-1.

2.

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.

Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB.

PLoS Pathog. 2014 Apr 3;10(4):e1004048. doi: 10.1371/journal.ppat.1004048. eCollection 2014 Apr.

3.

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL.

PLoS Pathog. 2011 Oct;7(10):e1002337. doi: 10.1371/journal.ppat.1002337. Epub 2011 Oct 27.

4.

Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.

Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH.

J Biol Chem. 2013 Jun 14;288(24):17261-71. doi: 10.1074/jbc.M112.438515. Epub 2013 May 6.

5.

IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.

Wrensch F, Winkler M, Pöhlmann S.

Viruses. 2014 Sep 26;6(9):3683-98. doi: 10.3390/v6093683.

6.

Alphavirus Restriction by IFITM Proteins.

Weston S, Czieso S, White IJ, Smith SE, Wash RS, Diaz-Soria C, Kellam P, Marsh M.

Traffic. 2016 Sep;17(9):997-1013. doi: 10.1111/tra.12416. Epub 2016 Jun 24.

7.

Identification of an endocytic signal essential for the antiviral action of IFITM3.

Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng YM, Liu SL, Guo F, Geng Y, Qiao W, Liang C.

Cell Microbiol. 2014 Jul;16(7):1080-93. doi: 10.1111/cmi.12262. Epub 2014 Feb 13.

8.

Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.

Blyth GA, Chan WF, Webster RG, Magor KE.

J Virol. 2015 Oct 14;90(1):103-16. doi: 10.1128/JVI.01593-15. Print 2016 Jan 1.

9.

Model of OSBP-Mediated Cholesterol Supply to Aichi Virus RNA Replication Sites Involving Protein-Protein Interactions among Viral Proteins, ACBD3, OSBP, VAP-A/B, and SAC1.

Ishikawa-Sasaki K, Nagashima S, Taniguchi K, Sasaki J.

J Virol. 2018 Mar 28;92(8). pii: e01952-17. doi: 10.1128/JVI.01952-17. Print 2018 Apr 15.

10.

UVRAG is required for virus entry through combinatorial interaction with the class C-Vps complex and SNAREs.

Pirooz SD, He S, Zhang T, Zhang X, Zhao Z, Oh S, O'Connell D, Khalilzadeh P, Amini-Bavil-Olyaee S, Farzan M, Liang C.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2716-21. doi: 10.1073/pnas.1320629111. Epub 2014 Feb 3.

11.

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.

Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT.

J Virol. 2010 Dec;84(24):12646-57. doi: 10.1128/JVI.01328-10. Epub 2010 Oct 13.

12.

Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses.

Benfield CT, Smith SE, Wright E, Wash RS, Ferrara F, Temperton NJ, Kellam P.

J Gen Virol. 2015 May;96(Pt 5):991-1005. doi: 10.1099/vir.0.000058. Epub 2015 Jan 22.

13.

pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion.

Desai TM, Marin M, Mason C, Melikyan GB.

J Biol Chem. 2017 May 12;292(19):7817-7827. doi: 10.1074/jbc.M117.783878. Epub 2017 Mar 24.

14.

IFITM3 polymorphism rs12252-C restricts influenza A viruses.

Williams DE, Wu WL, Grotefend CR, Radic V, Chung C, Chung YH, Farzan M, Huang IC.

PLoS One. 2014 Oct 14;9(10):e110096. doi: 10.1371/journal.pone.0110096. eCollection 2014.

15.

S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.

Yount JS, Karssemeijer RA, Hang HC.

J Biol Chem. 2012 Jun 1;287(23):19631-41. doi: 10.1074/jbc.M112.362095. Epub 2012 Apr 17.

16.

Sterol liganding of OSBP-related proteins (ORPs) regulates the subcellular distribution of ORP-VAPA complexes and their impacts on organelle structure.

Kentala H, Pfisterer SG, Olkkonen VM, Weber-Boyvat M.

Steroids. 2015 Jul;99(Pt B):248-58. doi: 10.1016/j.steroids.2015.01.027. Epub 2015 Feb 11.

PMID:
25681634
17.

The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.

Laliberte JP, Weisberg AS, Moss B.

PLoS Pathog. 2011 Dec;7(12):e1002446. doi: 10.1371/journal.ppat.1002446. Epub 2011 Dec 15.

18.

The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA.

Luyet PP, Falguières T, Pons V, Pattnaik AK, Gruenberg J.

Traffic. 2008 Dec;9(12):2279-90. doi: 10.1111/j.1600-0854.2008.00820.x. Epub 2008 Sep 24.

19.

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.

Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, Qiao W, Liang C.

J Virol. 2012 Dec;86(24):13697-707. doi: 10.1128/JVI.01828-12. Epub 2012 Oct 10.

20.

IFITM3 requires an amphipathic helix for antiviral activity.

Chesarino NM, Compton AA, McMichael TM, Kenney AD, Zhang L, Soewarna V, Davis M, Schwartz O, Yount JS.

EMBO Rep. 2017 Oct;18(10):1740-1751. doi: 10.15252/embr.201744100. Epub 2017 Aug 23.

Supplemental Content

Support Center